Amrize (NYSE:AMRZ) is one of the best IPO stocks to buy and hold for 3 years. On September 9, Oppenheimer analyst Bryan F. Blair initiated coverage of Amrize with an Outperform rating and $62 price target. Oppenheimer noted Amrize’s advantaged footprint and resource base, structural pricing power, and sustainable margin generation. The firm also highlighted Amrize’s prospects for double-digit earnings growth through the cycle Prior to this sentiment, Amrize delivered its Q2 2025 financial results, which r ...